Huabo Pharma was established on March 7, 2022. It is located in Saifu Industrial Park of Changjiangbu, Yingcheng, Hubei, (a provincial-level chemical Area).Huabo Pharma covers land area of 90000 square meters with planned total investment 300 million RMB, and it is specialized in production of APIs and intermediates including Ribavirin , Gliptins series, Tatins series and Sartans series etc....
It has become a major production base in China and enjoys high popularity in the industry